The decreased level or loss of activity of NEIL2 and, to a lesser extent, NEIL1, is a risk factor for the progression of cancers such as lung cancer and squamous cell carcinoma in the oral cavity [38,39,40,41], and poor survival in patients with estrogen-receptor-positive breast cancer [42]. This evidence concerns the gene NEIL2 and cancer.